Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation

Transpl Int. 2015 Oct;28(10):1162-71. doi: 10.1111/tri.12606. Epub 2015 Jun 2.

Abstract

The role of visceral adipose tissue (VAT) in post-transplant hyperglycaemia is not known. We evaluated 167 patients without diabetes 8-10 weeks after kidney transplantation, performing oral glucose tolerance tests and measuring VAT content from dual-energy X-ray absorptiometry scans. Median VAT weight in normal glucose tolerance patients was 0.9 kg, impaired fasting glucose patients 1.0 kg, impaired glucose tolerance patients 1.3 kg and patients with post-transplant diabetes (PTDM) 2.1 kg (P = 0.004, indicating a difference between groups). Percentage VAT of total body fat was associated with fasting (R(2) = 0.094, P < 0.001) and 2-h glucose concentration (R(2) = 0.062, P = 0.001), while BMI was only associated with 2-h glucose concentration (R(2) = 0.029, P = 0.028). An association between BMI and 2-h glucose concentration was lost in adjusted models, as opposed to the associations between VAT as percentage of total body fat and glucose concentrations (R(2) = 0.132, P < 0.001 and R(2) = 0.097, P = 0.001, respectively for fasting and 2-h glucose concentration). In conclusion, VAT is more closely related to impaired glucose metabolism than BMI after kidney transplantation. The association with central obesity should encourage additional studies on lifestyle interventions to prevent PTDM.

Keywords: HOMA-IR index; insulin resistance; kidney transplantation; new-onset diabetes mellitus; post-transplant diabetes mellitus; visceral fat.

MeSH terms

  • Absorptiometry, Photon
  • Adult
  • Aged
  • Blood Glucose / analysis
  • Body Composition
  • Body Mass Index
  • Cross-Sectional Studies
  • Diabetes Mellitus / chemically induced
  • Diabetes Mellitus / etiology*
  • Diabetes Mellitus / metabolism
  • Glucose / metabolism*
  • Glucose Tolerance Test
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents / adverse effects
  • Insulin / blood
  • Insulin Resistance*
  • Intra-Abdominal Fat / diagnostic imaging
  • Intra-Abdominal Fat / metabolism*
  • Kidney Transplantation*
  • Lipids / blood
  • Methylprednisolone / adverse effects
  • Middle Aged
  • Postoperative Complications / etiology*
  • Postoperative Complications / metabolism
  • Prednisolone / adverse effects
  • Rituximab / therapeutic use
  • Tissue Donors

Substances

  • Blood Glucose
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Insulin
  • Lipids
  • Rituximab
  • Prednisolone
  • Glucose
  • Methylprednisolone